AXT stock offering
- AXT announced a public stock offering to fund expanded indium phosphide production aimed at exports. - The capital raise is intended to increase specialised materials capacity in its supply chain. - Such financing actions create consulting opportunities around capacity planning, working-capital modelling and scaling operations (stocktitan.net).
AXT said on April 20 it plans to sell common stock to raise cash for more indium phosphide wafer production at its China-based subsidiary Tongmei. (sec.gov) The Fremont, California, company filed a preliminary prospectus with the Securities and Exchange Commission on April 20 and said the shares would be sold to institutional investors. AXT also said underwriters would get a 30-day option to buy up to 15% more shares. (sec.gov) AXT did not disclose the number of shares or the price in the initial filing. The company said net proceeds would go primarily to Beijing Tongmei Xtal Technology Co., Ltd. to expand indium phosphide substrate capacity for exports worldwide, plus research and development, working capital and general corporate purposes. (stocktitan.net) Indium phosphide is a semiconductor material used in optical communications and other high-speed electronics. AXT said in February that it expected first-quarter 2026 growth to be driven primarily by indium phosphide demand tied to artificial-intelligence infrastructure build-outs. (investors.axt.com) The fundraise follows a larger capital raise four months earlier. On December 29, 2025, AXT priced an $87 million public offering of 7,098,492 shares at $12.25 each, with proceeds also earmarked mainly for Tongmei’s indium phosphide expansion, research and development, and working capital. (investors.axt.com) AXT’s filings show why the capacity push is complicated. The company is incorporated in Delaware and based in Fremont, but it says all of its products are manufactured in China by subsidiaries and joint ventures. (sec.gov) That structure has run into export controls. In its annual report, AXT said China added indium phosphide substrates to its export control list on February 4, 2025, requiring export permits from China’s Ministry of Commerce for Tongmei’s wafer product lines. (sec.gov) Management said those permits were a bottleneck in late 2025. In results released on February 19, 2026, Chief Executive Officer Morris Young said AXT received fewer export permits in the fourth quarter than it had expected, though some permits had arrived in 2026. (investors.axt.com) The same February report showed the strain on the business. AXT posted 2025 revenue of $88.3 million, down from $99.4 million in 2024, and a net loss of $21.3 million for the year. (investors.axt.com) For investors, the next step is the final prospectus, which will set the share count and price. For AXT, the offering is another bet that demand for indium phosphide will outlast the export paperwork slowing shipments today. (sec.gov)
